Effects of Nicotine on Urinary Bladder Carcinogenesis

Area of Science:

• Oncology
• Toxicology
• Molecular Biology

Background:

• Epidemiological studies link tobacco smoking to increased urinary bladder cancer risk.
• The specific role of nicotine, separate from genotoxic carcinogens, in bladder cancer remains unclear.

Purpose of the Study:

• To review experimental evidence on nicotine's carcinogenic effects in urinary bladder carcinogenesis.
• To elucidate the molecular mechanisms underlying nicotine's role in bladder cancer development.

Main Methods:

• A two-stage rat carcinogenesis model was employed.
• Nicotine administration and its effects on urothelial carcinoma incidence, multiplicity, and cell proliferation were assessed.
• Molecular pathways involving nicotinic acetylcholine receptors (nAChRs) and signaling cascades were investigated.

Main Results:

• Nicotine significantly increased the incidence and multiplicity of invasive urothelial carcinoma in rats.
• Nicotine alone induced hyperplasia but not tumors, suggesting an enhancing role.
• Nicotine promotes cell proliferation via nAChRs (e.g., α7 subunit) activating STAT3/ERK1/2 pathways and via urothelial cytotoxicity leading to regenerative proliferation.
• Cotinine, a nicotine metabolite, also induced proliferation via nAChRs without cytotoxicity.

Conclusions:

• Nicotine acts as a tumor-enhancing agent in urinary bladder carcinogenesis, rather than a direct DNA-reactive carcinogen.
• Nicotine contributes to bladder cancer risk through mechanisms promoting cell proliferation, either directly or secondary to cytotoxicity.
• Understanding these mechanisms is crucial for assessing nicotine's role in tobacco-related bladder cancer.